Answer:
Thermosensitive liposomes (TSL) are promising tools used to deliver drugs to targeted region when local hyperthermia is applied (∼40–42°C) which triggers the membrane phase transformation from a solid gel-like state to a highly permeable liquid state. Selective lipid components have been used to in TSL formulations to increase plasma stability before hyperthermia and speed drug release rate after. Two generations of TSL technology have been developed. The traditional thermal sensitive liposomes (TTSL) have utilized DPPC and DSPC as a combination. The second generation, lysolipid thermally sensitive liposomes (LTSL) technology, has been developed with incorporation of lysolipids that form stabilized defects at phase transition temperature. LTSL maintains certain favorable attributes:
High percentage of lysolipids incorporation;
Minimum leakage for therapeutical drugs encapsulation;
Ultrafast drug release upon heating (3.5 times enhanced compared to TTSL). For example, ThermoDox, a commonly used LTSL drug for cancer, has been reported to release 100% of the encapsulated doxorubicin within 30s;
First and most successful formulation for intravascular drug release.
Explanation:
https://www.creative-biostructure.com/Lysolipid-Thermally-Sensitive-Liposomes-Production-612.htm
Probability of Green seed * Red flowers * Green pods
3/4 * 3/4 * 3/4 =27/64
Answer:
Why does the amount or dose entering the body matter? ... A point would be reached where beneficial effects would disappear and harmful effects would start to be noticed. ... harmful is directly related to the amount of it taken into the body at one time. ... Chemicals with high toxicity only need small doses to cause poisoning.
Explanation:
"By growing a bud" is the one way among the following choices given in the question that <span>an adult hydra produce a new hydra. The correct option among all the options that are given in the question is the third option or option "C". I hope that this is the answer that has actually come to your desired help.</span>
